Expression of B7-H3 in diffuse large B-cell lymphoma and its prognostic significance
10.3760/cma.j.cn115356-20211020-00242
- VernacularTitle:B7-H3在弥漫大B细胞淋巴瘤中的表达及其预后意义
- Author:
Shibing CHEN
1
;
Yue WANG
;
Meiying FAN
;
Zheng WANG
;
Bo WANG
;
Kaiqin JIANG
;
Xin LYU
Author Information
1. 临沂市中心医院血液内科，临沂 276400
- Keywords:
Lymphoma, large B-cell, diffuse;
Prognosis;
B7-H3
- From:
Journal of Leukemia & Lymphoma
2022;31(3):156-160
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the expression of B7-H3 in diffuse large B-cell lymphoma (DLBCL) and its prognostic significance.Methods:The paraffin-embedded tumor tissues of 103 patients with newly diagnosed DLBCL in Linyi Central Hospital from May 2013 to May 2019 were detected by using immunohistochemistry. The association of the expression of B7-H3 protein with the clinicopathological features, progression-free survival (PFS) and overall survival (OS) of DLBCL patients was analyzed. Cox proportional hazards model was used to analyze the factors affecting PFS and OS.Results:The positive rate of B7-H3 protein in patients with DLBCL was 68.0% (70/103). There were no statistically significant differences in the positive rate of B7-H3 protein among patients with different gender, age, clinical staging, international prognostic index (IPI) score, treatment effect, B symptoms, pathological type and other clinicopathological characteristics (all P > 0.05). The 5-year PFS and 5-year OS rates were 24% and 32% in all patients, the 5-year PFS rates were 47% and 14% in B7-H3 negative and B7-H3 positive patients, respectively ( P < 0.01); and 5-year OS rates were 50% and 24% in B7-H3 negative and B7-H3 positive patients, respectively ( P < 0.001). Multi-factor Cox regression analysis showed that B7-H3 positive was an adverse affecting factor of PFS ( HR = 2.685, 95% CI 1.503 - 4.789, P = 0.001) and OS ( HR = 2.262, 95% CI 1.248 - 4.098, P = 0.007). Conclusions:The moderate and high expression of B7-H3 may be related to the poor prognosis of DLBCL patients.
